Research Article
Oral Lesions: Poor Markers of Virologic Failure in HIV-Infected Patients on Antiretroviral Therapy
Table 2
HIV patients initiating ART with or without oral lesions (OL) by concurrent virologic status at baseline, 6, 12, 18, and 24 months (
).
| | Status in time | Without OL | With OL | All patients | -value | | (%) | (%) | (%) |
| | Baseline VL1 (copies/mL) | OL at baseline | OL at baseline | | | | <10,000 | 212 (39.8) | 22 (15.9) | 234 (34.9) | <0.01 | | ≥10,000 | 320 (60.2) | 116 (84.1) | 436 (65.1) |
| | 6-month VL (copies/mL) | OL at 6 months | OL at 6 months | | | | <10,000 | 283 (72.8) | 6 (54.5) | 289 (72.3) | 0.18 | | ≥10,000 | 106 (27.2) | 5 (45.5) | 111 (27.8) |
| | 12-month VL (copies/mL) | OL at 12 months | OL at 12 months | | | | <10,000 | 261 (78.4) | 1 (20.0) | 262 (77.5) | <0.012 | | ≥10,000 | 72 (21.6) | 4 (80.0) | 76 (22.5) |
| | 18-month VL (copies/mL) | OL at 18 months | OL at 18 months | | | | <10,000 | 252 (77.3) | 4 (66.7) | 256 (77.1) | 0.622 | | ≥10,000 | 74 (22.7) | 2 (33.3) | 76 (22.9) |
| | 24-month VL (copies/mL) | OL at 24 months | OL at 24 months | | | | <10,000 | 212 (75.4) | 0 (0.0) | 212 (74.9) | 0.062 | | ≥10,000 | 69 (24.6) | 2 (100.0) | 71 (25.1) |
|
|
1VL: viral load. 2Fisher’s exact test.
|
